Prescribing Dialysis Orders in Acute Kidney Injury
Initiate renal replacement therapy (RRT) emergently when life-threatening complications exist—specifically severe hyperkalemia with ECG changes, pulmonary edema unresponsive to diuretics, severe metabolic acidosis, uremic complications (encephalopathy, pericarditis, bleeding), or severe fluid overload causing respiratory compromise. 1, 2, 3
Absolute Indications for Emergent Dialysis
Do not wait for arbitrary BUN or creatinine thresholds alone when life-threatening complications are present 1, 4:
- Severe hyperkalemia with ECG changes (peaked T waves, widened QRS, loss of P waves) 1, 2, 3
- Pulmonary edema refractory to diuretic therapy with respiratory compromise 1, 2, 3
- Severe metabolic acidosis with impaired respiratory compensation 2, 3
- Uremic complications: encephalopathy, pericarditis, or uremic bleeding 1, 2, 3
- Severe fluid overload causing respiratory compromise, especially with anuria or oliguria 2, 3
Modality Selection Algorithm
For Hemodynamically Unstable Patients (on vasopressors):
Use continuous renal replacement therapy (CRRT) rather than intermittent hemodialysis 1, 3. CRRT is specifically indicated for:
- Patients requiring vasopressor support 3
- Acute brain injury or increased intracranial pressure 3
- Patients on extracorporeal life support (ECMO/ECCO2R) 1, 3
- Severe fluid overload unresponsive to diuretics 3
For Hemodynamically Stable Patients:
Use intermittent hemodialysis for rapid correction of severe hyperkalemia due to faster potassium clearance 1, 2, 3
CRRT Prescription Parameters
Effluent Dose:
- Deliver 20-25 mL/kg/h effluent volume for all CRRT modalities 1, 2, 3
- Prescribe higher than target dose because delivered dose is typically lower than prescribed due to downtime and interruptions 3
Replacement Fluid Selection:
- Use bicarbonate-based replacement fluids rather than lactate-based solutions, especially in shock, liver failure, or lactic acidemia 1, 3
- Lactate-containing solutions should be reserved only for hemodynamically stable patients without liver dysfunction 3
Anticoagulation Strategy:
- First-line: Regional citrate anticoagulation for patients without contraindications (offers longer filter life and lower bleeding risk) 1, 3
- For citrate contraindications: Use unfractionated or low-molecular-weight heparin 1
- For trauma or bleeding-prone patients: Use minimal or no anticoagulation 1, 2
Blood Flow and Ultrafiltration:
- Avoid excessive fluid removal that may cause hypotension and impede renal recovery 3, 5
- Pre-dilution of replacement fluid can enhance ultrafiltration rates and reduce filter clotting 3
Intermittent Hemodialysis Prescription Parameters
Dialysis Dose:
Deliver a Kt/V of 3.9 per week when using intermittent or extended RRT 1, 2
Treatment Frequency:
- Standard: 3 times per week 1
- In hypercatabolic states (e.g., crush injury, rhabdomyolysis): May require daily or even multiple treatments per day to control potassium 1
Technical Parameters:
- Blood flow rate: Typically 250-400 mL/min (adjust based on vascular access and hemodynamic tolerance)
- Dialysate flow rate: Typically 500-800 mL/min
- Treatment duration: 3-4 hours per session to achieve target Kt/V 1
Vascular Access
First choice: Right internal jugular vein 3
- Second choice: Femoral vein (avoid in high BMI patients) 3
- Third choice: Left internal jugular vein 3
- Last resort: Subclavian vein (higher thrombosis/stenosis risk) 3
Use uncuffed non-tunneled dialysis catheter for acute initiation; consider cuffed catheter if prolonged RRT anticipated 3
Monitoring Requirements During RRT
- Electrolytes and acid-base status: Monitor regularly, with particular vigilance for CRRT-induced hypokalemia and hypophosphatemia 3
- Fluid balance: Assess every 6-12 hours in critically ill patients 5
- Hemodynamic parameters: Use dynamic indices like passive leg-raising test or pulse pressure variation 5
- For citrate anticoagulation: Monitor ionized calcium and total calcium/ionized calcium ratio to detect citrate accumulation 3
Target Laboratory Values
- Potassium: Maintain 4.0-5.0 mEq/L 2
- Bicarbonate: Target >18-20 mEq/L 3
- Fluid balance: Avoid cumulative fluid overload >10-15% of body weight (associated with adverse outcomes and delayed renal recovery) 5, 6
- BUN: While not an absolute threshold, BUN >75 mg/dL in asymptomatic patients may indicate need for dialysis 4
Transitioning from CRRT to Intermittent Hemodialysis
Consider transition when all of the following are met 1, 3:
- Vasopressor support has been discontinued 1, 3
- Hemodynamic stability achieved 1, 3
- Intracranial hypertension (if present) has resolved 1, 3
- Fluid balance can be adequately controlled by intermittent hemodialysis 1, 3
Discontinuation Criteria
- Kidney recovery: Sustained independence from RRT for minimum of 14 days 2, 3
- Assessment of residual function: Perform 24-hour urine collection to measure urine volume and creatinine/urea clearance 3
- When RRT no longer aligns with patient's overall care goals 3
Common Pitfalls to Avoid
- Do not base initiation solely on absolute creatinine or BUN values—consider the broader clinical context and trajectory of disease 1, 4
- Do not assume normal creatinine during RRT indicates renal recovery—serum creatinine is artificially reduced by dialysis, not by kidney function improvement 3
- Avoid 0.9% saline for fluid resuscitation—use balanced crystalloids (lactated Ringer's) to prevent metabolic acidosis and hyperchloremia 5, 6
- Do not use hydroxyethyl starches—associated with increased mortality and worsened AKI 5
- Avoid excessive fluid removal—can cause hypotension and delay renal recovery 3, 5
Special Considerations
For Patients on ECMO/ECCO2R:
- CRRT is more appropriate due to hemodynamic instability 1
- Earlier RRT may be required for preventing and managing fluid overload 1
- Heparin administration may depend on patient bleeding risk and circuit setup 1
For Crush Injury/Rhabdomyolysis:
- May require daily or multiple dialysis treatments to control hyperkalemia 1
- Intermittent hemodialysis provides rapid potassium clearance and ability to treat multiple patients per day on same machine 1
Post-Obstructive (Postrenal) AKI:
- Relief of obstruction is primary treatment 2
- After bilateral obstruction relief, monitor for massive polyuria requiring careful fluid and electrolyte replacement 2
- Replace 80-100% of measured losses with lactated Ringer's 2
- Potassium replacement typically requires 1-3 mmol/kg/day during polyuric phase 2, 5